Tested Anti-Estro v3
Natural health product licensed in Canada
- Other names
- Tested Anti-Estro
- Licence holder
- Supplement Facts Inc. / Canada 3587843 Inc.
- NPN or DIN-HM
- 80145577
- Status
- Active licence
- Licence date
- 25 November 2025
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lepidium meyenii Source : Lepidium meyenii - racine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 600 mg | 150 mg | Not calculated |
| Centella asiatica Extract : Matériel brut sec Extraction ratio : 30:1 Dry plant equivalent : 3.75 g | 125 mg | Not calculated |
| 3,3'-Diindolylméthane Source : 3,3'-diindolylméthane | 80 mg | Not calculated |
| (E)-5-(p-hydroxystyryl)resorcinol Source : Resvératrol | 60 mg | Not calculated |
| D-saccharate de calcium Source : Saccharate de calcium | 150 mg | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 150 mg Potency : 85 % Oligomeric Proanthocyanidins | 30 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, L-Leucine, Poudre d'Oryza Sativa (Riz), Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps reduce the severity and duration of symptoms associated with recurrent breast pain (cyclical mastalgia). Helps to support/promote healthy estrogen metabolism/balance. Source of antioxidants/Provides antioxidants that help fight/protect (cell) against/reduce (the oxidative effect of/the oxidative damage caused by/cell damage caused by) free radicals. Source of antioxidants/Provides antioxidants.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80145577
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.